Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2018; 14(03): 211-212DOI: 10.1055/a-0644-9420 Studienreferate Georg Thieme Verlag KG Stuttgart · New York Kommentar Alexander Zipprich Recommend Article Abstract Buy Article All articles of this category Comment on: Humanalbumingabe verlängert Leben von Patienten mit dekompensierter ZirrhoseGastroenterologie up2date 2018; 14(03): 211-211DOI: 10.1055/a-0644-9397 Full Text References Literatur 1 Caraceni P, Riggio O, Angeli P. et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 2018; 391: 2417-2429 2 Gerbes AL, Gülberg V, Sauerbruch T. et al. German S3-guideline “ascites, spontaneous bacterial peritonitis, hepatorenal syndrome”. Z Gastroenterol 2011; 49: 749-779 3 Ripoll C, Groszmann R, Garcia-Tsao G. et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488 4 Bernardi M, Ricci CS, Zaccherini G. Role of human albumin in the management of complications of liver cirrhosis. J Clin Exp Hepatol 2014; 4: 302-311 5 Casper M, Mengel M, Fuhrmann C. et al. The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial. Trials 2015; 16: 83